Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A50747 | 35279807 | Indian J Gastroenterol | Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis. | 2022 | Details |
| A50756 | 35276968 | Nutrients | Metabolism and Health Effects of Rare Sugars in a CACO-2/HepG2 Coculture Model. | 2022 | Details |
| A50773 | 35270077 | Plants (Basel) | Effects of the Water Extract of Fermented Rice Bran on Liver Damage and Intestinal Injury in Aged Rats with High-Fat Diet Feeding. | 2022 | Details |
| A50787 | 35266816 | mBio | Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota. | 2022 | Details |
| A50788 | 35266164 | Aliment Pharmacol Ther | Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know. | 2022 | Details |
| A50948 | 31402898 | Front Endocrinol (Lausanne) | Editorial: Gastrointestinal Hormones. | 2019 | Details |
| A50958 | 30852101 | Arab J Gastroenterol | Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD). | 2019 | Details |
| A50959 | 30779368 | Hepatology | The Intestinal Microbiome, Plasma Metabolome, and Liver Transcriptome: A Conspiracy Driving Hepatic Steatosis. | 2019 | Details |
| A50976 | 29279470 | Intern Med | Glycogen Hepatopathy: An Under-recognized Hepatic Complication of Uncontrolled Type 1 Diabetes Mellitus. | 2017 | Details |
| A51111 | 35702368 | Int J Gen Med | Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. | 2022 | Details |
| A51133 | 35575233 | Am J Physiol Endocrinol Metab | Increased gut serotonin production in response to bisphenol A structural analogs may contribute to their obesogenic effects. | 2022 | Details |
| A51134 | 35559233 | Front Pharmacol | Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology. | 2022 | Details |
| A51142 | 35511325 | J Microbiol | Host-microbial interactions in metabolic diseases: from diet to immunity. | 2022 | Details |
| A51148 | 35470867 | J Food Biochem | Dietary sinapic acid attenuated high-fat diet-induced lipid metabolism and oxidative stress in male Syrian hamsters. | 2022 | Details |
| A51152 | 35460276 | Hepatology | Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis. | 2022 | Details |
| A51184 | 35317174 | World J Hepatol | Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. | 2022 | Details |
| A51186 | 35296424 | Biochim Biophys Acta Mol Cell Biol Lipids | Mechanisms of intestinal triacylglycerol synthesis. | 2022 | Details |
| A51230 | 9622394 | Alcohol Clin Exp Res | An enzyme immune assay for serum anti-acetaldehyde adduct antibody using low-density lipoprotein adduct and its significance in alcoholic liver injury. | 1998 | Details |
| A51241 | 6180628 | Am J Clin Pathol | The significance of giant mitochondria in liver biopsies as observed by light microscopy. | 1982 | Details |
| A51244 | 5423890 | Gastroenterology | Diminished micellar phase lipid in patients with chronic nonalcoholic liver disease and steatorrhea. | 1970 | Details |
| A51281 | 7449415 | Curr Concepts Nutr | Alcohol, nutrition, and liver disease. | 1980 | Details |
| A51301 | 35797110 | J Med Chem | Discovery of (E)-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis. | 2022 | Details |
| A51309 | 35711841 | J Cancer | Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer. | 2022 | Details |
| A51319 | 35644437 | J Ethnopharmacol | Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. | 2022 | Details |
| A51333 | 35535115 | J Clin Exp Hepatol | Bleeding Stomal Varices and Their Interventional Management- A Series of Three Cases. | 2021 | Details |
| A51350 | 35399809 | Curr Ther Res Clin Exp | The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records. | 2022 | Details |
| A51359 | 35308208 | Front Pharmacol | Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. | 2022 | Details |
| A51398 | 35814685 | Front Microbiol | Saccharomyces Boulardii Ameliorates Non-alcoholic Steatohepatitis in Mice Induced by a Methionine-Choline-Deficient Diet Through Gut-Liver Axis. | 2022 | Details |
| A51428 | 35514019 | Dig Liver Dis | Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis. | 2022 | Details |
| A51430 | 35472625 | Mol Cell Endocrinol | Immunomodulatory functions of FXR. | 2022 | Details |
| A51520 | 35668935 | Front Pharmacol | Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats. | 2022 | Details |
| A51526 | 35592303 | Can J Infect Dis Med Microbiol | A Novel Predictive Model in Recognizing Severe COVID-19 and Multiorgan Injuries: Platelet-to-CRP Ratio. | 2022 | Details |
| A51540 | 35457118 | Int J Mol Sci | Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | 2022 | Details |
| A51560 | 35128832 | Adv Sci (Weinh) | Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis. | 2022 | Details |
| A51603 | 35740108 | Antioxidants (Basel) | The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease. | 2022 | Details |
| A51617 | 35618993 | J Gastrointest Surg | Sleeve Gastrectomy Improves High-Fat Diet-Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats. | 2022 | Details |
| A51624 | 35508517 | Trends Endocrinol Metab | Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease. | 2022 | Details |
| A51630 | 35483558 | Biochim Biophys Acta Mol Cell Biol Lipids | The effect of black seed (Nigella sativa) extract on lipid metabolism in HepG2 cells. | 2022 | Details |
| A51633 | 35473811 | Br J Nutr | Metabolic adaptation to high starch diet in largemouth bass (Micropterus salmoides) was associated with the restoration of metabolic functions via inflammation, bile acid synthesis and energy metabolism. | 2022 | Details |
| A51650 | 35271353 | Am J Physiol Gastrointest Liver Physiol | Microbial metabolites: cause or consequence in gastrointestinal disease? | 2022 | Details |
| A51669 | 35070060 | World J Diabetes | Gut microbiota-derived metabolites are novel targets for improving insulin resistance. | 2022 | Details |
| A51681 | 34959746 | Nutrients | Blueberry Counteracts Prediabetes in a Hypercaloric Diet-Induced Rat Model and Rescues Hepatic Mitochondrial Bioenergetics. | 2021 | Details |
| A51691 | 34904027 | World J Hepatol | Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis. | 2021 | Details |
| A51693 | 34864457 | Clin Nutr | The effects of different parenteral nutrition lipid formulations on clinical and laboratory endpoints in patients receiving home parenteral nutrition: A systematic review. | 2021 | Details |
| A51699 | 34818545 | Cell Rep | The asymmetric Pitx2 gene regulates gut muscular-lacteal development and protects against fatty liver disease. | 2021 | Details |
| A51714 | 34684436 | Nutrients | Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet. | 2021 | Details |
| A51716 | 34660695 | Front Mol Biosci | Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD. | 2021 | Details |
| A51723 | 34596865 | Hepatol Int | Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. | 2021 | Details |
| A51737 | 34460287 | Infect Immun | The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections. | 2021 | Details |
| A51744 | 34417593 | Nat Metab | Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity. | 2021 | Details |
| A51745 | 34414128 | Front Cell Infect Microbiol | Integrative Longitudinal Analysis of Metabolic Phenotype and Microbiota Changes During the Development of Obesity. | 2021 | Details |
| A51759 | 34307440 | Front Nutr | The Intestinal Microbiome Predicts Weight Loss on a Calorie-Restricted Diet and Is Associated With Improved Hepatic Steatosis. | 2021 | Details |
| A51771 | 34236076 | Clin Sci (Lond) | Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress. | 2021 | Details |
| A51772 | 34233623 | Cell Mol Biol Lett | Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease. | 2021 | Details |
| A51776 | 34153347 | Food Chem Toxicol | Dietary nanoparticles alter the composition and function of the gut microbiota in mice at dose levels relevant for human exposure. | 2021 | Details |
| A51797 | 34030573 | Gut Microbes | Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. | 2021 | Details |
| A51801 | 34013499 | Hu Li Za Zhi | [Nutritional Care in Acute and Chronic Illness]. | 2021 | Details |
| A51811 | 33953584 | Diabetes Metab Syndr Obes | Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System. | 2021 | Details |
| A51828 | 33874858 | Gut Microbes | Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. | 2022 | Details |
| A51831 | 33847205 | Gut Microbes | Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns. | 2022 | Details |
| A51837 | 33809061 | Cells | Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge. | 2021 | Details |
| A51838 | 33806985 | Nutrients | Soluble Fiber Inulin Consumption Limits Alterations of the Gut Microbiota and Hepatic Fatty Acid Metabolism Caused by High-Fat Diet. | 2021 | Details |
| A51840 | 33785557 | Gut | Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. | 2021 | Details |
| A51842 | 33777186 | Exp Ther Med | Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice. | 2021 | Details |
| A51848 | 33746902 | Front Endocrinol (Lausanne) | The Impact of Gut Microbiome on Metabolic Disorders During Catch-Up Growth in Small-for-Gestational-Age. | 2021 | Details |
| A51890 | 33436764 | Sci Rep | Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. | 2021 | Details |
| A51896 | 33383372 | Biomed Pharmacother | Improvements in estrogen deficiency-induced hypercholesterolemia by Hypericum perforatum L. extract are associated with gut microbiota and related metabolites in ovariectomized (OVX) rats. | 2020 | Details |
| A51915 | 33273482 | Sci Rep | NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet. | 2020 | Details |
| A51923 | 33221593 | Environ Int | Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice. | 2020 | Details |
| A51927 | 33168600 | Gut | Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function. | 2020 | Details |
| A51930 | 33144308 | mSystems | Correlations between α-Linolenic Acid-Improved Multitissue Homeostasis and Gut Microbiota in Mice Fed a High-Fat Diet. | 2020 | Details |
| A51959 | 32902315 | Am J Physiol Gastrointest Liver Physiol | Effects of dietary components on intestinal permeability in health and disease. | 2020 | Details |
| A51962 | 32864127 | J Anim Sci Biotechnol | Role of nutraceuticals during the transition period of dairy cows: a review. | 2020 | Details |
| A51966 | 32825248 | Nutrients | Biomarkers of Broccoli Consumption: Implications for Glutathione Metabolism and Liver Health. | 2020 | Details |
| A51970 | 32811503 | BMC Musculoskelet Disord | H. Pylori is related to osteoporosis but only in premenopausal female: a cross-sectional study. | 2020 | Details |
| A51978 | 32663609 | Biochim Biophys Acta Mol Cell Biol Lipids | Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD. | 2020 | Details |
| A51979 | 32662541 | J Food Biochem | Effect of banana pulp dietary fibers on metabolic syndrome and gut microbiota diversity in high-fat diet mice. | 2020 | Details |
| A51981 | 32633236 | J Physiol Pharmacol | COVID-19 - more than respiratory disease: a gastroenterologist's perspective. | 2020 | Details |
| A51987 | 32595984 | Cell Death Discov | The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation. | 2020 | Details |
| A51991 | 32548470 | ACS Omega | Effects of Inulin Propionate Ester on Obesity-Related Metabolic Syndrome and Intestinal Microbial Homeostasis in Diet-Induced Obese Mice. | 2020 | Details |
| A51995 | 32530501 | Hepatology | Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population-Based Study of 1,355 Adults. | 2021 | Details |
| A52009 | 32359213 | Mol Nutr Food Res | Novel Strategies to Prevent Total Parenteral Nutrition-Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes. | 2020 | Details |
| A52023 | 32200644 | Am J Physiol Gastrointest Liver Physiol | Fermentable fibers induce rapid macro- and micronutrient depletion in Toll-like receptor 5-deficient mice. | 2020 | Details |
| A52034 | 32079675 | J Biol Chem | Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export. | 2020 | Details |
| A52036 | 32059815 | J Pediatr | Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease. | 2020 | Details |
| A52044 | 31935236 | PLoS One | OGG1 deficiency alters the intestinal microbiome and increases intestinal inflammation in a mouse model. | 2020 | Details |
| A52048 | 31904482 | Cancer Lett | Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. | 2020 | Details |
| A52056 | 31822562 | J Biol Chem | Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice. | 2019 | Details |
| A52058 | 31786232 | Biochimie | Vegetable lecithins: A review of their compositional diversity, impact on lipid metabolism and potential in cardiometabolic disease prevention. | 2019 | Details |
| A52062 | 31743877 | Biomed Pharmacother | An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ). | 2019 | Details |
| A52073 | 31669075 | Dig Liver Dis | Risk of chemotherapy-associated liver injury (CALI) in PNPLA3 p.148M allele carriers: Preliminary results of a transient elastography-based study. | 2019 | Details |
| A52082 | 31559327 | GE Port J Gastroenterol | Fatty Liver and Autoimmune Hepatitis: Two Forms of Liver Involvement in Lipodystrophies. | 2019 | Details |
| A52084 | 31554181 | Nutrients | Role of Oleic Acid in the Gut-Liver Axis: From Diet to the Regulation of Its Synthesis via Stearoyl-CoA Desaturase 1 (SCD1). | 2019 | Details |
| A52096 | 31307210 | FASEB J | Ileal interposition surgery targets the hepatic TGF-β pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD-T2DM rat model of diabetes. | 2019 | Details |
| A52125 | 30971183 | Circ Res | Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk. | 2019 | Details |
| A52127 | 30944419 | Int J Obes (Lond) | Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity. | 2019 | Details |
| A52131 | 30920846 | Am J Physiol Gastrointest Liver Physiol | Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice. | 2019 | Details |
| A52134 | 30861583 | JPEN J Parenter Enteral Nutr | Long-Term Use of Mixed-Oil Lipid Emulsion in Soybean Oil-Intolerant Home Parenteral Nutrition Patients. | 2019 | Details |
| A52136 | 30839437 | Eur J Gastroenterol Hepatol | Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference. | 2019 | Details |
| A52166 | 30481177 | PLoS One | A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone. | 2018 | Details |